These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2526534)

  • 1. Dual action of prostaglandin E2 in allergic inflammation.
    Hedqvist P; Raud J; Dahlén SE
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():539-42. PubMed ID: 2526534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravital microscopic studies on acute mast cell-dependent inflammation.
    Raud J
    Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation.
    Raud J
    Br J Pharmacol; 1990 Mar; 99(3):449-54. PubMed ID: 2158843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periarteriolar localization of mast cells promotes oriented interstitial migration of leukocytes in the hamster cheek pouch.
    Raud J; Lindbom L; Dahlèn SE; Hedqvist P
    Am J Pathol; 1989 Jan; 134(1):161-9. PubMed ID: 2536521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 reverses indomethacin-induced enhancement of acute allergic inflammation in the hamster cheek pouch.
    Raud J; Dahlén SE; Hedqvist P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():908-12. PubMed ID: 2960204
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin E2 prevents diclofenac-induced enhancement of histamine release and inflammation evoked by in vivo challenge with compound 48/80 in the hamster cheek pouch.
    Raud J; Sydbom A; Dahlén SE; Hedqvist P
    Agents Actions; 1989 Aug; 28(1-2):108-14. PubMed ID: 2476919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
    Chung KF
    Sci STKE; 2005 Sep; 2005(303):pe47. PubMed ID: 16189372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators.
    Harizi H; Gualde N
    Cell Mol Immunol; 2006 Aug; 3(4):271-7. PubMed ID: 16978535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release.
    Raud J; Dahlén SE; Sydbom A; Lindbom L; Hedqvist P
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2315-9. PubMed ID: 2451246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2.
    Tanaka M; Ishibashi H; Hirata Y; Miki K; Kudo J; Niho Y
    J Clin Lab Immunol; 1996; 48(1):17-31. PubMed ID: 10332631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mast cells and basophilic leukocytes in allergic inflammation].
    Bukilica M; Bogić M; Andrejević S; Nikolić B
    Srp Arh Celok Lek; 1997; 125(11-12):363-9. PubMed ID: 9480572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2.
    Oppenheimer-Marks N; Kavanaugh AF; Lipsky PE
    J Immunol; 1994 Jun; 152(12):5703-13. PubMed ID: 8207201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression.
    Spengler RN; Spengler ML; Strieter RM; Remick DG; Larrick JW; Kunkel SL
    J Immunol; 1989 Jun; 142(12):4346-50. PubMed ID: 2723432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis.
    Chan SC; Kim JW; Henderson WR; Hanifin JM
    J Immunol; 1993 Sep; 151(6):3345-52. PubMed ID: 8397256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells.
    Leal-Berumen I; O'Byrne P; Gupta A; Richards CD; Marshall JS
    J Immunol; 1995 May; 154(9):4759-67. PubMed ID: 7536779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular actions of histamine: synergism with leukotriene B4 and role in allergic leucocyte recruitment.
    Thorlacius H; Lindbom L; Hedqvist P; Raud J
    Clin Exp Allergy; 1997 Apr; 27(4):445-51. PubMed ID: 9146939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism.
    Marshall JS; Gomi K; Blennerhassett MG; Bienenstock J
    J Immunol; 1999 Apr; 162(7):4271-6. PubMed ID: 10201958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prostaglandins and indomethacin on the cellular inflammatory response following surgical trauma in fetal rabbits.
    Morykwas MJ; Perry SL; Argenta LC
    Int J Tissue React; 1993; 15(4):151-6. PubMed ID: 8188454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.